125 related articles for article (PubMed ID: 19204888)
1. Comparison of phenotypes in male and female individuals of a new family with Dunnigan type of familial partial lipodystrophy due to a lamin A/C R482W mutation.
Laudes M; Oberhauser F; Walgenbach K; Schubert M; Schulte DM; Faust M; Krone W
Horm Metab Res; 2009 May; 41(5):414-7. PubMed ID: 19204888
[No Abstract] [Full Text] [Related]
2. The p.R482W substitution in A-type lamins deregulates SREBP1 activity in Dunnigan-type familial partial lipodystrophy.
Vadrot N; Duband-Goulet I; Cabet E; Attanda W; Barateau A; Vicart P; Gerbal F; Briand N; Vigouroux C; Oldenburg AR; Lund EG; Collas P; Buendia B
Hum Mol Genet; 2015 Apr; 24(7):2096-109. PubMed ID: 25524705
[TBL] [Abstract][Full Text] [Related]
3. Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -γ (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutations.
Demir T; Onay H; Savage DB; Temeloglu E; Uzum AK; Kadioglu P; Altay C; Ozen S; Demir L; Cavdar U; Akinci B
Diabet Med; 2016 Oct; 33(10):1445-50. PubMed ID: 26756202
[TBL] [Abstract][Full Text] [Related]
4. The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks.
Briand N; Guénantin AC; Jeziorowska D; Shah A; Mantecon M; Capel E; Garcia M; Oldenburg A; Paulsen J; Hulot JS; Vigouroux C; Collas P
Hum Mol Genet; 2018 Apr; 27(8):1447-1459. PubMed ID: 29438482
[TBL] [Abstract][Full Text] [Related]
5. Dunnigan-type familial partial lipodystrophy associated with the heterozygous R482W mutation in LMNA gene - case study of three women from one family.
Nabrdalik K; Strózik A; Minkina-Pędras M; Jarosz-Chobot P; Młynarski W; Grzeszczak W; Gumprecht J
Endokrynol Pol; 2013; 64(4):306-11. PubMed ID: 24002959
[TBL] [Abstract][Full Text] [Related]
6. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499
[TBL] [Abstract][Full Text] [Related]
7. Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A/C mutations.
Subramanyam L; Simha V; Garg A
Clin Genet; 2010 Jul; 78(1):66-73. PubMed ID: 20041886
[TBL] [Abstract][Full Text] [Related]
8. Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660).
Lanktree M; Cao H; Rabkin SW; Hanna A; Hegele RA
Clin Genet; 2007 Feb; 71(2):183-6. PubMed ID: 17250669
[No Abstract] [Full Text] [Related]
9. Lipodystrophic laminopathy: Lamin A mutation relaxes chromatin architecture to impair adipogenesis.
Elzeneini E; Wickström SA
J Cell Biol; 2017 Sep; 216(9):2607-2610. PubMed ID: 28811278
[TBL] [Abstract][Full Text] [Related]
10. The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress.
Verstraeten VL; Caputo S; van Steensel MA; Duband-Goulet I; Zinn-Justin S; Kamps M; Kuijpers HJ; Ostlund C; Worman HJ; Briedé JJ; Le Dour C; Marcelis CL; van Geel M; Steijlen PM; van den Wijngaard A; Ramaekers FC; Broers JL
J Cell Mol Med; 2009 May; 13(5):959-71. PubMed ID: 19220582
[TBL] [Abstract][Full Text] [Related]
11. The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation.
Wojtanik KM; Edgemon K; Viswanadha S; Lindsey B; Haluzik M; Chen W; Poy G; Reitman M; Londos C
J Lipid Res; 2009 Jun; 50(6):1068-79. PubMed ID: 19201734
[TBL] [Abstract][Full Text] [Related]
12. [Familial partial lipodystrophy (Dunnigan syndrome) due to LMNA gene mutation: The first description of its clinical case in Russia].
Sorkina EL; Kalashnikova MF; Melnichenko GA; Tyulpakov AN
Ter Arkh; 2015; 87(3):83-87. PubMed ID: 26027246
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of Fragile X-related protein 1 by the lipodystrophic lamin A p.R482W mutation elicits a myogenic gene expression program in preadipocytes.
Oldenburg AR; Delbarre E; Thiede B; Vigouroux C; Collas P
Hum Mol Genet; 2014 Mar; 23(5):1151-62. PubMed ID: 24108105
[TBL] [Abstract][Full Text] [Related]
14. Lipodystrophy: an unusual diagnosis in a case of oligomenorrhea and hirsutism.
Keller J; Subramanyam L; Simha V; Gustofson R; Minjarez D; Garg A
Obstet Gynecol; 2009 Aug; 114(2 Pt 2):427-431. PubMed ID: 19622949
[TBL] [Abstract][Full Text] [Related]
15. LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A.
Tu Y; Sánchez-Iglesias S; Araújo-Vilar D; Fong LG; Young SG
Nucleus; 2016 Sep; 7(5):512-521. PubMed ID: 27841971
[TBL] [Abstract][Full Text] [Related]
16. Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism.
Vantyghem MC; Faivre-Defrance F; Marcelli-Tourvieille S; Fermon C; Evrard A; Bourdelle-Hego MF; Vigouroux C; Defebvre L; Delemer B; Wemeau JL
Clin Endocrinol (Oxf); 2007 Aug; 67(2):247-9. PubMed ID: 17524034
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2.
Resende ATP; Martins CS; Bueno AC; Moreira AC; Foss-Freitas MC; de Castro M
Clin Endocrinol (Oxf); 2019 Jul; 91(1):94-103. PubMed ID: 30954027
[TBL] [Abstract][Full Text] [Related]
18. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C.
Speckman RA; Garg A; Du F; Bennett L; Veile R; Arioglu E; Taylor SI; Lovett M; Bowcock AM
Am J Hum Genet; 2000 Apr; 66(4):1192-8. PubMed ID: 10739751
[TBL] [Abstract][Full Text] [Related]
19. Familial partial lipodystrophy presenting as metabolic syndrome.
Chan D; McIntyre AD; Hegele RA; Don-Wauchope AC
J Clin Lipidol; 2016; 10(6):1488-1491. PubMed ID: 27919367
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy.
Hegele RA; Cao H; Anderson CM; Hramiak IM
J Clin Endocrinol Metab; 2000 Sep; 85(9):3431-5. PubMed ID: 10999845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
